Being in the Israeli Economic Mission we continuously receive information on Israeli Medical innovations and meet the companies who wish to explore Indian markets. Recently we interacted with an Israeli company OCON which prevents pregnancy and would like to be introduce to relevant stakeholders in India. OCON specializes in hormone-free spherical intrauterine contraceptive.

 

Female sterilization is the most common contraceptive method used worldwide. The Contraception industry is assisting to prevent unwanted pregnancies, particularly among the teenage women. Less than half of women are also found to consider non-contraceptive medical benefits, such as medication for prolonged menstrual bleeding, menstrual cramping, and acne, as motives for use.

 

One of the methods to prevent pregnancy is use of intrauterine devices. An intrauterine device (IUD) is a small, often T-shaped birth control device that is inserted into the uterus to prevent pregnancy. IUDs are one form of long-acting reversible birth control. IUDs can be both hormonal and nonhormonal and are over 99 percent effective to control birth.

 

Understanding the myriad of issues women face with rigid T-shaped IUDs, an Israeli company, OCON created the IUB™ Ballerine® to be uniquely spherical and small (15 mm in diameter). It also demonstrates an improved safety profile, leading to fewer perforations, malposition, and ectopic pregnancies.

 

OCON’s lead product, the IUB™ Ballerine® hormone-free spherical intrauterine contraceptive, is marketed in nearly 20 countries with over 60,000 users to date. The company is also developing a strong pipeline using the IUB™ frame for hormonal contraception, abnormal uterine bleeding and infertility with additional products in early discovery.

 

The device has already received four global regulatory approvals, including Conformité Européenne’s (CE) approval. It is suitable for young women from 15 years of age who wish to delay pregnancy as their fertility is not affected upon removing the device. Its exceptional properties have increased its acceptance rates among women of different age groups and position the company for continued domination of the feminine tech space.

 

(Source: https://oconmed.com/)

 

For more information:

Tejinder Singh (Tejinder.Singh@israeltrade.gov.il)